Literature DB >> 29210098

Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country.

A D Farmer1,2,3, A-M L Wegeberg1,4, B Brock5, A R Hobson6, S D Mohammed2, S M Scott2, C E Bruckner-Holt3, J R Semler7, W L Hasler8, P M Hellström9, A M Drewes1, C Brock1,10.   

Abstract

BACKGROUND: The wireless motility capsule concurrently measures temperature, pH and pressure as it traverses the gastrointestinal tract. AIMS: To describe normative values for motility/contractility parameters across age, gender and testing centres.
METHODS: Healthy participants underwent a standardised wireless motility capsule assessment following an overnight fast and consumption of a meal of known nutritional content. Traces were divided into regions of interest and analysed using 2 software packages (MotiliGI and GIMS Data Viewer). Inter-observer agreement was independently assessed by 2 investigators.
RESULTS: Normative data for motility/contractility parameters (maximum amplitude, mean peak amplitude, contraction frequency and motility index) are presented for 107 individuals (62 male, median age 40 years, range 18-78). MotiliGI-Gastric, small bowel and colonic maximal contraction amplitude correlated with age (r = .24, P = .01; r = .22, P = .02; and r = .2, P = .04 respectively). Small bowel motility index was higher in females than males (150.4 ± 12 vs 122 ± 7.6, P = .04). Inter-observer agreement was excellent for transit times, pH and contractility/motility parameters. GIMS Data viewer-Gastric, small bowel and colonic loge motility index correlated with the respective area under the contraction curve, total contractions, sum of amplitudes and contraction frequency (all r>.35, P < .0003) but not with transit times.
CONCLUSIONS: Our analysis provides normative data for motility/contractility parameters. Log motility index summarises a number of measures. In future, the measurement of contractile activity with the wireless motility capsule may potentially aid in the diagnosis of disease states such as visceral myopathic disorders.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 29210098     DOI: 10.1111/apt.14438

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

1.  Gastrointestinal pH, Motility Patterns, and Transit Times After Roux-en-Y Gastric Bypass.

Authors:  Louise Ladebo; Pernille V Pedersen; Grzegorz J Pacyk; Jens Peter Kroustrup; Asbjørn M Drewes; Christina Brock; Anne E Olesen
Journal:  Obes Surg       Date:  2021-03-12       Impact factor: 4.129

2.  Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial.

Authors:  Anne-Marie Langmach Wegeberg; Christian Stevns Hansen; Adam D Farmer; Jesper Scott Karmisholt; Asbjorn M Drewes; Poul Erik Jakobsen; Birgitte Brock; Christina Brock
Journal:  United European Gastroenterol J       Date:  2020-05-09       Impact factor: 4.623

Review 3.  Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers.

Authors:  Adam D Farmer; Caroline Bruckner-Holt; Susanne Schwartz; Emma Sadler; Sri Kadirkamanthan
Journal:  J Patient Cent Res Rev       Date:  2019-04-29

Review 4.  Recent Advances in the Management of Severe Gastrointestinal Dysmotility.

Authors:  Dipesh H Vasant; Simon Lal
Journal:  Clin Exp Gastroenterol       Date:  2021-05-10

Review 5.  Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.

Authors:  Laura Obici; Ole B Suhr
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

6.  Study protocol for a multicentre, randomised, parallel group, sham-controlled clinical trial investigating the effect of transcutaneous vagal nerve stimulation on gastrointestinal symptoms in people with diabetes complicated with diabetic autonomic neuropathy: the DAN-VNS Study.

Authors:  Tina Okdahl; Davide Bertoli; Birgitte Brock; Klaus Krogh; Filip Krag Knop; Christina Brock; Asbjørn M Drewes
Journal:  BMJ Open       Date:  2021-01-06       Impact factor: 2.692

7.  Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule.

Authors:  Mattis Bekkelund; Dag A Sangnes; Eirik Søfteland; Lars Aabakken; Martin Biermann; Elisabeth K Steinsvik; Trygve Hausken; Georg Dimcevski; Jan Gunnar Hatlebakk
Journal:  Clin Exp Gastroenterol       Date:  2021-04-28

8.  Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls.

Authors:  Dag A Sangnes; Katarina Lundervold; Mattis Bekkelund; Hilde L von Volkmann; Birgitte Berentsen; Odd Helge Gilja; Georg Dimcevski; Eirik Søfteland
Journal:  United European Gastroenterol J       Date:  2021-10-23       Impact factor: 4.623

9.  Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.

Authors:  Jonas S Quist; Marie M Jensen; Kim K B Clemmensen; Hanne Pedersen; Natasja Bjerre; Joachim Størling; Martin B Blond; Nicolai J Wewer Albrechtsen; Jens J Holst; Signe S Torekov; Dorte Vistisen; Marit E Jørgensen; Satchidananda Panda; Christina Brock; Graham Finlayson; Kristine Færch
Journal:  BMJ Open       Date:  2020-08-26       Impact factor: 2.692

Review 10.  Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives.

Authors:  Ditte S Kornum; Astrid J Terkelsen; Davide Bertoli; Mette W Klinge; Katrine L Høyer; Huda H A Kufaishi; Per Borghammer; Asbjørn M Drewes; Christina Brock; Klaus Krogh
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.